Investigation confirms an AI infrastructure biological contamination incident, tracing a rare, deadly pathogen to Meta's data ...

Through predictive modelling, AI supports target identification, prediction of physicochemical properties and formulation strategy selection.

Anthropic also went a step further, saying it would develop drugs of its own. Head of life sciences Eric Kauderer-Abrams said ...

AI-driven small molecule discovery, which underlies most drugs on the market, is a challenge being tackled through science and technology ...

Process analytical technology enables data-driven scale-up by embedding real-time analytics from development through ...

Researchers at the Purdue Institute for Cancer Research (PICR) have developed a next-generation technology platform designed to accelerate one of the slowest and most challenging stages of cancer drug ...

Design of targeted protein degraders is more than target degradation. Linker architecture, molecular flexibility, solubility, permeability, synthesis, purification, and formulation can all influence ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

Tempus AI Inc. (NASDAQ:TEM) is one of the top 10 hidden AI stocks to buy. On May 31, Tempus AI launched the next generation ...

Xaira is an integrated biotechnology company built to deliver on the promise of AI to help transform the drug discovery and development process Dr. Ian McCaffery joins from AbbVie, where he served as ...

Researchers at UMass Amherst have combined high-throughput laboratory screening with an AI neural network to identify ...

In a paper published in Proceedings of the National Academy of Sciences, researchers from Technion and Tel Aviv University ...